Syros Pharmaceuticals (SYRS) PT Lowered to $6 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein lowered the price target on Syros Pharmaceuticals (NASDAQ: SYRS) to $6.00 (from $15.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
